Alpha Tau Medical Ltd. Ordinary Shares

DRTS

...

DRTS: Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors.

Show DRTS Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of DRTS by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by DRTS's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

Patent Title: Treatment planning for alpha particle radiotherapy Jun. 06, 2023
Patent Title: Treatment planning for alpha particle radiotherapy Jun. 06, 2023
Patent Title: Polymer coatings for brachytherapy devices Dec. 20, 2022
Patent Title: Method and device for radiotherapy Aug. 28, 2018

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on DRTS's company Twitter account

WallStreetBets

Number of mentions of DRTS in WallStreetBets Daily Discussion

DRTS News

Recent insights relating to DRTS

CNBC Recommendations

Recent picks made for DRTS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DRTS

Corporate Flights

Flights by private jets registered to DRTS